Skip To Main Content
Abby Proch on Muck Rack

Abby Proch

Verified
(She/Her)
Pittsburgh
As seen in: Clinical Leader, PA Consulting, Friends of Cancer Research, RF Globalnet, Photonics Online, Cell & Gene, Wireless Design Online
Covers:  Clinical research and trials, drug development, biotech

Get in touch with Abby

Contact Abby, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Abby Proch’s Journalist Portfolio

What Clinical Trial Experts Think Will Happen With AI In 2024

What Clinical Trial Experts Think Will Happen With AI In 2024

In part one of this preview of clinical trials trends for 2024, experts discuss the applications of AI in cli…

View article →
What Experts Think Will Happen With Patient Centricity In 2024

What Experts Think Will Happen With Patient Centricity In 2024

In part two, experts discuss patient centricity themes, including diversity, equity, and inclusion (DEI) and …

View article →
What Clinical Trial Experts Think Will Happen With DCTs In 2024

What Clinical Trial Experts Think Will Happen With DCTs In 2024

In part three of this preview of clinical trials trends, experts discuss the state of decentralized trials in…

View article →
Which Therapeutic Areas Experts Think Will Gain Traction In 2024

Which Therapeutic Areas Experts Think Will Gain Traction In 2024

In part four, experts discuss several therapeutic areas and their advancements they believe deserve and will …

View article →
4 Things I'm Looking Forward To At SCOPE 2024

4 Things I'm Looking Forward To At SCOPE 2024

The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Pro…

View article →

Articles

06.10.26 -- AI Amplifying Capabilities And Risks: The Legal Consequences Of AI In Clinical Research

|
By Abby Proch Verified, Geert Jan Groeneveld, Jeffrey P. Hodge
| Clinical Leader Verified
Turning global phase III breast cancer trial complexity into confident delivery In the competitive landscape of breast cancer research, speed and efficiency are paramount. While managing complexity is critical, successfully running a global trial demands a clear, integrated strategy. Aligning biomarker testing, regulatory pathways and regional operations from day one creates a streamlined path to faster enrollment and stronger outcomes.
Open in Who Shared Issue with article?

What's The Role Of HEOR For A Clinical Researcher? A Perspective From ISPOR 2026

|
By Abby Proch Verified
| Clinical Leader Verified
By Abby Proch, Executive Editor I’ve only been on the clinical research scene for a handful of years, and last week’s ISPOR conference in Philadelphia was my first. It’s a health and economic outcomes research (HEOR) event, with conversations, poster presentations, and vendor booths — much of which pertain to commercialization. Typically, everything related to commercialization, including market access, pricing, reimbursement, and formulary decisions, is outside my purview.
Open in Who Shared Issue with article?

06.01.26 -- Why Site Engagement Isn't Just A Role Anymore

|
By Katie C. Mowry, Abby Proch Verified, Dan Schell Verified
| Clinical Leader Verified
The Patient-Centered Trial Paradigm For Knee Osteoarthritis Although PROs can complicate a trial design, they're essential to reflecting a patient’s true knee OA experience and producing meaningful evidence, explains Katie Mowry, Ph.D., VP of R&D at Organogensis. When Participants Need Help, Someone's Got To Respond Support for clinical trial participants helps you ensure requests are handled clearly and in line with study guidelines by managing travel, reimbursements, and logistics.
Open in Who Shared Issue with article?
See all 161 articles